Bortezomib inhibits the survival and proliferation of bone marrow stromal cells

BACKGROUND: Bortezomib is widely used for the treatment of multiple myeloma. Bone marrow stromal cells (BMSCs) endow myeloma cells with survival and growth advantages. However, the influence of bortezomib on BMSCs is not well elucidated. We examined the effects of bortezomib on the survival and grow...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Res
Главные авторы: Kim, Ha-Yon, Moon, Ji-Young, Ryu, Haewon, Choi, Yoon-Seok, Song, Ik-Chan, Lee, Hyo-Jin, Yun, Hwan-Jung, Kim, Samyong, Jo, Deog-Yeon
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486164/
https://ncbi.nlm.nih.gov/pubmed/26157778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.2.87
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы